USPTO serial 79326220
TELUM THERAPEUTICS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 28, 2023
- Examiner
- MESSICK, TABITHA LEE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with TELUM THERAPEUTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
John G. Tutunjian
John G. Tutunjian Tutunjian & Bitetto, P.C.401 Broadhollow RoadSutie 402Melville, NY 11747Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic preparations for scientific purposes; reagents for medical research use; reagents for medical research in the field of infectious diseases and diseases caused by bacteria; diagnostic reagents for scientific or research use; enzymes for scientific purposes; diagnostic kits comprising specimen receptors being biological tissues cultures and reagents for testing for selected bacteria, other than for medical or veterinary use | ACTIVE | — |
| 005 | Pharmaceutical products for the treatment of infectious diseases; pharmaceutical products for the treatment of diseases caused by bacteria; antibacterial pharmaceuticals; antibiotics; pharmaceutical preparations, namely, biopharmaceuticals for the treatment of infectious diseases; pharmaceutical preparations, namely, immunotherapeutic agents for bacterial infections; enzyme preparations for medical purposes; enzymes for medical purposes; enzymes and enzyme preparations for medical purposes for the diagnosis, prognosis and treatment of infectious diseases and diseases caused by bacteria; assays, biomarkers and reagents for medical purposes for the diagnosis, prognosis and treatment of infectious diseases and diseases caused by bacteria | ACTIVE | — |
| 042 | Biomedical research services; scientific research for medical purposes in the field of infectious diseases and diseases caused by bacteria; research and development of pharmaceutical products, antibiotics, assays, biomarkers and reagents for the diagnosis, prognosis and treatment of infectious diseases and diseases caused by bacteria; research and development of immunotherapeutic agents for bacterial infections; research and development of enzymes, enzyme preparations and synthetic proteins for the diagnosis, prognosis and treatment of infectious diseases and diseases caused by bacteria; conducting clinical trials for others of pharmaceutical products, antibiotics, assays, biomarkers and reagents for the diagnosis, prognosis and treatment of infectious diseases and diseases caused by bacteria | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by TELUM THERAPEUTICS S.L.
- Other trademarks owned by TELUM THERAPEUTICS S.L.
- Other trademarks owned by TELUM THERAPEUTICS S.L.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named TELUM THERAPEUTICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 7, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 18, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 18, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 28, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 28, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Mar 28, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 24, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 10, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 10, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 4, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 4, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Dec 21, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 2, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 17, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 16, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 16, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 23, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 29, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 29, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 3, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 2, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 28, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 23, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 19, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 18, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |